P - Caution when used during Pregnancy.
L - Caution when used during Lactation.
Chlorothiazide sodium is a diuretic used within the hospital setting or for personal use to manage excess fluid associated with congestive heart failure. It is also used as an antihypertensive.
Chlorothiazide reduces the reabsorption of electrolytes from the renal tubules, hence increasing the excretion of sodium and chloride ions and consequently of water. It also reduces the glomerular filtration rate.
Orally used in the treatment of hypertension and oedema.
Electrolyte imbalance; hyperglycaemia; gout; dry mouth; thirst; weakness; muscle pain and cramp; seizures; hypotension; GI disturbances; anorexia; sialadenitis; headache; impotence; yellow vision; hypersensitivity reactions; cholestatic jaundice; pancreatitis; blood dyscrasias; glycosuria; dizziness; photosensitivity reactions, postural hypotension, paraesthesia.
Information Not Available.
Fluid and electrolyte disturbances; hepatic cirrhosis; gout; DM. Elderly; severe heart failure; renal or hepatic impairment. When administered IV, ensure that extravasation does not occur. Monitor blood glucose concentrations in patients taking antidiabetics. Pregnancy and lactation.
Digitalis glycosides; drugs that prolong QT interval; other antihypertensives; competitive muscle relaxants; pressor amines; corticosteroids, corticotrophin; β2-agonists, α-blockers; ACE inhibitors; NSAIDs; alcohol, barbiturates; opioids; lithium; allopurinol; tetracyclines; carbenoxolone; hypoglycaemics.
Should be taken with food.
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).
Severe hepatic or renal impairment; anuria; Addison's disease; hypercalcaemia.
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.